Physician profile
Cliff Caudill
NPI 1841300712
$8,366.39
in general payments reported to CMS, 2019-2025
15 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $205 · 2021: $930 · 2022: $5,983 · 2023: $220 · 2024: $417 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495 · Consulting Fee: $200 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $100 · Travel and Lodging: $19.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $495.38 |
| Consulting Fee | $200.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $100.00 |
| Travel and Lodging | $19.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $5,877.78 | 2022 | |
| Allergan, INC. | $1,074.31 | 2019-2021 | |
| Abbvie INC. | $458.73 | 2022-2024 | Durysta, Vuity |
| Alcon Vision LLC | $247.45 | 2019-2025 | Air Optix, Hydrus Microstent |
| Coopervision INC. | $213.60 | 2019-2025 | Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $200.00 | 2019-2025 | Acuvue |
| Shire North American Group INC | $65.96 | 2019 | |
| Lombart Brothers, INC. | $52.64 | 2020 | |
| Sun Pharmaceutical Industries INC. | $42.33 | 2023 | Cequa |
| Carl Zeiss Meditec USA, INC. | $39.55 | 2024 | Cirrus Hd-Oct |
| Stryker Corporation | $36.27 | 2021 | |
| Bausch & Lomb Americas INC. | $19.36 | 2024 | Multi-Focal |
| Maculogix, INC. | $14.15 | 2019 | |
| Topcon Healthcare, INC. | $12.62 | 2022 | |
| Derma Sciences, INC. | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cliff Caudill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.